Vivek Rathi

625 total citations
20 papers, 398 citations indexed

About

Vivek Rathi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Vivek Rathi has authored 20 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Vivek Rathi's work include Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (5 papers) and RNA modifications and cancer (3 papers). Vivek Rathi is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (5 papers) and RNA modifications and cancer (3 papers). Vivek Rathi collaborates with scholars based in Australia, United States and Netherlands. Vivek Rathi's co-authors include Ariena Kersbergen, Sarah A. Best, Matthew E. Ritchie, Gavin Wright, David P. De Souza, Malcolm J. McConville, Saravanan Dayalan, Antonia N. Policheni, Dedreia Tull and Daniel H.D. Gray and has published in prestigious journals such as Nature Communications, Cell Metabolism and Oncogene.

In The Last Decade

Vivek Rathi

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivek Rathi Australia 10 202 142 113 110 39 20 398
Jie Yao China 14 212 1.0× 168 1.2× 120 1.1× 92 0.8× 28 0.7× 51 488
Kaijing Wang China 13 177 0.9× 134 0.9× 117 1.0× 87 0.8× 29 0.7× 35 417
Longci Sun China 9 197 1.0× 71 0.5× 127 1.1× 53 0.5× 32 0.8× 17 327
Kaimi Li China 12 211 1.0× 102 0.7× 132 1.2× 138 1.3× 32 0.8× 15 397
Xianli He China 10 242 1.2× 96 0.7× 143 1.3× 142 1.3× 37 0.9× 19 469
Weiying Li China 11 143 0.7× 97 0.7× 106 0.9× 126 1.1× 13 0.3× 29 363
Kyle M. LaPak United States 6 187 0.9× 63 0.4× 55 0.5× 113 1.0× 28 0.7× 11 353
Rujun Mo China 13 282 1.4× 120 0.8× 147 1.3× 115 1.0× 26 0.7× 21 454
Huohui Ou China 10 280 1.4× 97 0.7× 212 1.9× 81 0.7× 32 0.8× 16 405
Jenny Han United States 9 218 1.1× 81 0.6× 67 0.6× 61 0.6× 50 1.3× 21 352

Countries citing papers authored by Vivek Rathi

Since Specialization
Citations

This map shows the geographic impact of Vivek Rathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Rathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Rathi more than expected).

Fields of papers citing papers by Vivek Rathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Rathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Rathi. The network helps show where Vivek Rathi may publish in the future.

Co-authorship network of co-authors of Vivek Rathi

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Rathi. A scholar is included among the top collaborators of Vivek Rathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Rathi. Vivek Rathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azad, Arun, et al.. (2025). BRCA Mutation Testing in Men With Metastatic Castration‐Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice. Asia-Pacific Journal of Clinical Oncology. 21(4). 345–358.
2.
Klebe, Sonja, Vivek Rathi, & Prudence A. Russell. (2024). Lung cancer caused by asbestos: What a reporting pathologist needs to know. Lung Cancer. 195. 107849–107849. 1 indexed citations
3.
Ng, Jessica M.Y., et al.. (2022). Clear Cell Sarcoma of the Kidney (CCSK) With BCOR-CCNB3 Fusion: A Rare Case Report With a Brief Review of the Literature. Pediatric and Developmental Pathology. 26(2). 149–152. 3 indexed citations
4.
Rathi, Vivek, et al.. (2022). Understanding Xacro Misunderstandings. 2022 International Conference on Robotics and Automation (ICRA). 6247–6252. 3 indexed citations
5.
Rathi, Vivek, et al.. (2021). Genomic and Clinical Significance of Multiple Primary Lung Cancers as Determined by Next-Generation Sequencing. Journal of Thoracic Oncology. 16(7). 1166–1175. 30 indexed citations
6.
Villalobos, Joel, Hugh J. McDermott, Peter McNeill, et al.. (2020). Slim electrodes for improved targeting in deep brain stimulation. Journal of Neural Engineering. 17(2). 26008–26008. 3 indexed citations
7.
Itchins, Malinda, Amanda L. Hudson, Sarah A. Hayes, et al.. (2020). ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling. The Oncologist. 25(8). 641–649. 8 indexed citations
8.
Best, Sarah A., Ariena Kersbergen, Xueyi Dong, et al.. (2019). Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma. Nature Communications. 10(1). 4190–4190. 71 indexed citations
9.
Gately, Lucy, Sue‐Anne McLachlan, Jennifer Philip, Vivek Rathi, & Anthony Dowling. (2019). Molecular profile of long-term survivors of glioblastoma: A scoping review of the literature. Journal of Clinical Neuroscience. 68. 1–8. 13 indexed citations
10.
Chou, Angela, Ian Brown, M. Priyanthi Kumarasinghe, et al.. (2019). RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas. Modern Pathology. 33(4). 657–664. 21 indexed citations
11.
Rathi, Vivek, et al.. (2019). Implementation of fuzzy logic control for FOPDT model of distillation column. 1. 1294–1298. 4 indexed citations
12.
Best, Sarah A., David P. De Souza, Ariena Kersbergen, et al.. (2018). Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment. Cell Metabolism. 27(4). 935–943.e4. 151 indexed citations
13.
Best, Sarah A., et al.. (2018). FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium. Oncogene. 37(46). 6096–6104. 14 indexed citations
15.
Donaldson, Christopher, et al.. (2017). Adenoid Cystic Carcinoma Presenting as Abducens Nerve Palsy Secondary to Cavernous Sinus Lesion. Annals of Neurosciences. 24(3). 187–190. 2 indexed citations
18.
McKelvie, Penelope, Alan A. McNab, Thomas G. Hardy, & Vivek Rathi. (2016). Comparative Study of Clinical, Pathological, Radiological, and Genetic Features of Patients With Adult Ocular Adnexal Xanthogranulomatous Disease, Erdheim-Chester Disease, and IgG4-Related Disease of the Orbit/Ocular Adnexa. Ophthalmic Plastic and Reconstructive Surgery. 33(2). 112–119. 19 indexed citations
19.
Wright, Gavin, Hongdo Do, Jonathan M. Weiss, et al.. (2014). Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine. Oncotarget. 5(8). 2107–2115. 18 indexed citations
20.
Rathi, Vivek, et al.. (2010). Well-differentiated papillary mesothelioma in association with endometrial carcinoma: a case report.. PubMed. 54(5 Suppl). 793–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026